Related Experiment Video
Updated: May 4, 2026

05:39
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
1.4K
Taxanes as radiosensitizers.
Encouse B Golden1, Silvia C Formenti, Peter B Schiff
1Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA.
Anti-Cancer Drugs
|December 17, 2013
Summary
Taxanes enhance radiotherapy by targeting the
Area of Science:
- Radiation oncology
- Molecular biology
- Cancer research
Background:
- Radiotherapy's molecular mechanisms, including DNA damage, have been studied for decades.
- The 'four Rs' of radiobiology (reassortment, reoxygenation, repair, repopulation) are key to understanding treatment efficacy.
Purpose of the Study:
- To review the impact of taxanes on radiobiological principles.
- To explore how taxanes sensitize tumor cells to radiation therapy.
- To discuss the clinical implications of taxane-mediated radiosensitization.
Main Methods:
- Literature review of studies on taxanes and radiotherapy.
- Analysis of molecular mechanisms of radiosensitization.
- Examination of clinical outcomes associated with taxane and radiation combinations.
Main Results:
- Taxanes directly and indirectly radiosensitize tumor cells by affecting the tumor microenvironment.
- Manipulation of the 'four Rs' with taxanes improves tumor control probabilities.
- Taxanes demonstrate time- and dose-dependent effects on radiosensitization.
Conclusions:
- Taxanes represent a promising strategy for enhancing radiotherapy efficacy.
- Understanding taxane-induced radiosensitization can lead to improved cancer treatment protocols.
- Further research into taxane-radiobiology interactions is warranted for clinical application.
Related Concept Videos
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K

